BrainStorm

BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage biotechnology company developing autologous cell therapies for neurodegenerative diseases.

[BrainStorm @BrainstormCell]

We are honored to welcome @PeterPitts, former @US_FDA Associate Commissioner, to BrainStorm's Board of Directors. His expertise will help support our mission to advance NurOwn® for people living with ALS. #NurOwn #Biotech #FDA #ALS
Read more: https://t.co/2xnHjmCaeQ

[BrainStorm @BrainstormCell]

Global leadership and deep @FDA experience strengthen @BrainStormCell at a pivotal time.

@PeterPitts oversight of regulatory and financial strategy will enhance our ability to advance partnerships, investor discussions and the path forward for NurOwn®.

#ALS #NurOwn #Biotech

[BrainStorm @BrainstormCell]

BrainStorm is entering an important new chapter. We welcome former @FDA Associate Commissioner @PeterPitts as Executive Chairman as we work to advance the NurOwn® Phase 3b trial under an FDA Special Protocol Assessment.

https://t.co/MtNLoyRWkY

[BrainStorm @BrainstormCell]

Lou Gehrig's story is part of our history.

People living with ALS are fighting for their future.

Scientific progress is advancing rapidly. People living with ALS deserve every opportunity to benefit from it. @RCJAPH

https://t.co/Uhe0cZqKkA

#LouGehrigDay #StrikeOutALS

[BrainStorm @BrainstormCell]

As the #ALS community marks #LouGehrigDay, BrainStorm announced the publication of an article in @RCJAPH examining how advances in science, medicine, and technology are challenging regulatory frameworks to evolve alongside innovation.

Read: https://t.co/QUvIyK6dBy

[Peter J. Pitts @PeterPitts]

In 2002, I spoke at an ALS event in DC. After my talk, a patient said to me, "I'll be dead in a year. Please help make a cure possible." I promised that I would. And I intend to keep that promise. https://t.co/R0o5UkbYdB

[Cision/PR Newswire Israel @PRNewswireIL]

#BrainStorm #Cell #Therapeutics #Appoints #Former #FDA #Associate #Commissioner #Peter J. #Pitts to #Board of #Directors https://t.co/bLxsw6fAyX $BCLI @BrainstormCell

[BrainStorm @BrainstormCell]

A Citizen Petition was submitted to the FDA requesting a new review of data supporting NurOwn®.

We remain focused on advancing the ENDURANCE Phase 3b trial and exploring pathways that could bring meaningful options to people living with #ALS.
Here: https://t.co/ObN1fVHbEF

[BrainStorm @BrainstormCell]

📊 New ALS Survival Data
90% of #ALS participants in EAP for NurOwn® survived over 5 years, compared to the typical 10% survival rate. These real-world findings support the scientific rationale for the upcoming Phase 3b trial under FDA SPA. Read here: https://t.co/1GYZg94SHa

[BrainStorm @BrainstormCell]

ALS Awareness Month may be ending, but the stories stay with us.

🔊 Six voices.
🌟 Endless impact.
🌿 Quiet courage.
💙 Real support

Let’s carry them forward. Let’s keep showing up.

#MomentsThatMattered #ALSawareness #SupportIsStrength #BetterTogether #EndALS #Endurance

[BrainStorm @BrainstormCell]

Anne Snyder says Emma from the @youralsnetwork was a light in the dark, guiding her family through ALS and VA support. Sometimes the right person changes everything.

#MomentsThatMattered #ALSawareness #SupportIsStrength #BetterTogether #VeteransWithALS

[BrainStorm @BrainstormCell]

When Anne Snyder’s husband Leonard was diagnosed with ALS, the care team didn’t just give a diagnosis—they gave compassion. Words like “We’ll walk with you” meant everything. Kindness changes everything.
#MomentsThatMattered #Endurance #BetterTogether @youralsnetwork

[BrainStorm @BrainstormCell]

We’re partnering with @MinarisRM to manufacture NurOwn® for the upcoming Phase 3b #Endurance #ALS trial.
This step ensures aligned strategy and execution as we advance our #mission to bring forward a meaningful treatment. Read here: https://t.co/4NlJ0MVfZ2

#NurOwn

[BrainStorm @BrainstormCell]

Bill Olivier says his wife Karen’s love, strength & caregiving make all the difference in his ALS journey.

Support isn’t always loud—but it’s always powerful.
#MomentsThatMattered #ALSawareness #BetterTogether #SupportIsStrength #CaregiversMatter

[BrainStorm @BrainstormCell]

Bill Olivier found purpose through advocacy—thanks to the love of his family, friends & the support of groups like @ComCareALS, @IAMALSorg & @ALSAZ.

In #ALS, showing up makes all the difference.
#MomentsThatMattered #ALSawareness #BetterTogether #SupportIsStrength #Endurance

[BrainStorm @BrainstormCell]

#BetterTogether #Endurance

[BrainStorm @BrainstormCell]

Sometimes the strongest support is simply showing up—again and again.
When @cimbura_seide family needed help, their #community answered—with time, tools, and love.
That’s what made the difference.
#MomentsThatMattered #BetterTogether #SupportIsStrength #ALS

[BrainStorm @BrainstormCell]

When @cimbura_seide Dad had #ALS, her college equestrian community made sure she never felt alone.
They didn’t just offer words—they booked flights, checked in, and showed up. That’s what compassion looks like.
#MomentsThatMattered #ALSawareness #BetterTogether #EnduranceALS

[BrainStorm @BrainstormCell]

Sometimes the strongest support is simply showing up—again and again.
When @cimbura_seide family needed help, their #community answered—with time, tools, and love.
That’s what made the difference.
#MomentsThatMattered #BetterTogether #SupportIsStrength #ALS

[BrainStorm @BrainstormCell]

During today’s $BCLI earnings call, our CEO reflected on a powerful moment from the #ALS Drug Development Summit—Wendy, living with ALS, called every patient a warrior.

We stand with the ALS Community. The ENDURANCE trial is our commitment in action.

[BrainStorm @BrainstormCell]

The Phase 3b ENDURANCE trial of NurOwn® has been cleared by the @US_FDA under a Special Protocol Assessment (SPA).
This milestone reflects continued progress toward developing a potentially meaningful treatment option.
📄 Full release: https://t.co/r8GM1Z9TgP #EnduranceALS